65 related articles for article (PubMed ID: 14678211)
1. A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.
Johansson H; Lindstedt M; Albrekt AS; Borrebaeck CA
BMC Genomics; 2011 Aug; 12():399. PubMed ID: 21824406
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 4-methylcyclohexanemethanol (MCHM) in a combined irritancy and Local Lymph Node Assay (LLNA) in mice.
Johnson VJ; Auerbach SS; Luster MI; Waidyanatha S; Masten SA; Wolfe MS; Burleson FG; Burleson GR; Germolec DR
Food Chem Toxicol; 2017 Jul; 105():99-105. PubMed ID: 28343035
[TBL] [Abstract][Full Text] [Related]
3. Use of guinea pig data to obtain starting points for skin sensitisation risk assessment - A commentary.
Basketter D; Corea N; Corvaro M; Grivel A; Kluxen FM; Morgan N; Wiemann C
Regul Toxicol Pharmacol; 2024 Mar; 148():105584. PubMed ID: 38417477
[TBL] [Abstract][Full Text] [Related]
4. Use of human predictive patch test (HPPT) data for the classification of skin sensitization hazard and potency.
Herzler M; Abedini J; Allen DG; Germolec D; Gordon J; Ko HS; Matheson J; Reinke E; Strickland J; Thierse HJ; To K; Truax J; Vanselow JT; Kleinstreuer N
Arch Toxicol; 2024 May; 98(5):1253-1269. PubMed ID: 38483583
[TBL] [Abstract][Full Text] [Related]
5. The inter-laboratory validation study of EpiSensA for predicting skin sensitization potential.
Mizumachi H; Watanabe M; Ikezumi M; Kajiwara M; Yasuda M; Mizuno M; Imai N; Sakuma M; Shibata M; Watanabe SI; Motoyama J; Basketter D; Eskes C; Hoffmann S; Lehmann DM; Ashikaga T; Sozu T; Takeyoshi M; Suzuki S; Miyazawa M; Kojima H
J Appl Toxicol; 2024 Apr; 44(4):510-525. PubMed ID: 37897225
[TBL] [Abstract][Full Text] [Related]
6. Electrophilic Reactivity of Sulfated Alcohols in the Context of Skin Sensitization.
Roberts DW
Chem Res Toxicol; 2024 Jan; 37(1):16-19. PubMed ID: 38079418
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of murine local lymph node assay (LLNA) data for skin sensitization: Overload effects, danger signals and chemistry-based read-across.
Roberts DW
Curr Res Toxicol; 2021; 2():53-63. PubMed ID: 34345850
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking of BMDC assay and related QSAR study for identifying sensitizing chemicals.
Chedik L; Baybekov S; Marcou G; Cosnier F; Mourot-Bousquenaud M; Jacquenet S; Varnek A; Battais F
Regul Toxicol Pharmacol; 2024 May; 149():105623. PubMed ID: 38631606
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Methods for Analysis of Nanoparticles' Potential to Induce Delayed-Type Hypersensitivity Reactions.
Potter TM; Neun BW; Dobrovolskaia MA
Methods Mol Biol; 2024; 2789():193-207. PubMed ID: 38507005
[TBL] [Abstract][Full Text] [Related]
10. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dose-responses of contact allergens using the guinea pig maximization test and the local lymph node assay.
van Och FM; Vandebriel RJ; Prinsen MK; De Jong WH; Slob W; van Loveren H
Toxicology; 2001 Oct; 167(3):207-15. PubMed ID: 11578800
[TBL] [Abstract][Full Text] [Related]
12. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
Durand G; de Burlet G; Virat M; Nauman BD
Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
[TBL] [Abstract][Full Text] [Related]
13. Activity of human contact allergens in the murine local lymph node assay.
Ryan CA; Gerberick GF; Cruse LW; Basketter DA; Lea L; Blaikie L; Dearman RJ; Warbrick EV; Kimber I
Contact Dermatitis; 2000 Aug; 43(2):95-102. PubMed ID: 10945748
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
15. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
